Home
TEVA
TEVA News

Latest Teva Pharmaceutical Industries Limited (TEVA) News on April 2, 2025

MT Newswires

2 days ago

Teva Says Schizophrenia Trial Survey Results Show Patient Satisfaction With TEV-'749

New Data Strengthens Teva’s Schizophrenia Portfolio, Including Phase 3 SOLARIS Trial Survey Results Demonstrating Patient and Healthcare Professional Satisfaction with TEV-'749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable

GlobeNewswire

2 days ago

New Data Strengthens Teva’s Schizophrenia Portfolio, Including Phase 3 SOLARIS Trial Survey Results Demonstrating Patient and Healthcare Professional Satisfaction with TEV-'749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable

MT Newswires

2 days ago

Teva Pharmaceutical's Upcoming Cost-Optimization Plan May Offer Significant Benefits, UBS Says

These Are My 3 Worst-Performing Stocks So Far in 2025 -- and the One I'm Buying More of Now

Motley Fool

5 days ago

These Are My 3 Worst-Performing Stocks So Far in 2025 -- and the One I'm Buying More of Now

Teva to Host Conference Call to Discuss First Quarter 2025 Financial Results at 8 a.m. ET on May 7, 2025

GlobeNewswire

6 days ago

Teva to Host Conference Call to Discuss First Quarter 2025 Financial Results at 8 a.m. ET on May 7, 2025

Teva Releases Q1 2025 Aide Memoire

GlobeNewswire

6 days ago

Teva Releases Q1 2025 Aide Memoire

Motley Fool

9 days ago

Billionaire Stanley Druckenmiller Jettisoned Shares of Palantir and Nvidia, and Is Piling Into 3 High-Profile Turnaround Stocks

Was Jim Cramer Right About Teva Pharmaceutical Industries (TEVA)?

Insider Monkey

11 days ago

Was Jim Cramer Right About Teva Pharmaceutical Industries (TEVA)?

Teva Pharmaceutical Stock Scores RS Rating Upgrade

Investor's Business Daily

15 days ago

Teva Pharmaceutical Stock Scores RS Rating Upgrade

Teva Pharmaceutical Industries (NYSE:TEVA) Sees 14% Stock Price Rise With FDA Acceptance Of New Drug Application

Simply Wall St.

15 days ago

Teva Pharmaceutical Industries (NYSE:TEVA) Sees 14% Stock Price Rise With FDA Acceptance Of New Drug Application

Teva Upgrades Its 4PL Model, Enhancing Medicine Accessibility for Patients with Kerry Pharma

PR Newswire

19 days ago

Teva Upgrades Its 4PL Model, Enhancing Medicine Accessibility for Patients with Kerry Pharma

Teva debuts global campaign encouraging people to get outside

Retail Dive

22 days ago

Teva debuts global campaign encouraging people to get outside

MT Newswires

a month ago

Teva Pharmaceutical Industries Insider Sold Shares Worth $375,534, According to a Recent SEC Filing

MT Newswires

a month ago

Teva Pharmaceutical Industries Insider Sold Shares Worth $999,425, According to a Recent SEC Filing

MT Newswires

a month ago

Teva Pharmaceutical Industries Insider Sold Shares Worth $903,462, According to a Recent SEC Filing

Teva to Present at Barclays Global Healthcare Conference and Leerink Partners Global Healthcare Conferences in March

GlobeNewswire

a month ago

Teva to Present at Barclays Global Healthcare Conference and Leerink Partners Global Healthcare Conferences in March

Why Axsome Therapeutics, Inc. (AXSM) is Skyrocketing So Far in 2025

Insider Monkey

a month ago

Why Axsome Therapeutics, Inc. (AXSM) is Skyrocketing So Far in 2025

Is Teva Pharmaceuticals Industries Limited (TEVA) the Best Weight Loss Drug Stock to Buy According to Analysts?

Insider Monkey

a month ago

Is Teva Pharmaceuticals Industries Limited (TEVA) the Best Weight Loss Drug Stock to Buy According to Analysts?

Teva targets schizophrenia to build on innovative medicines growth

Pharma Voice

a month ago

Teva targets schizophrenia to build on innovative medicines growth

Is Teva Pharmaceutical Industries Limited (TEVA) the Best Low Price Pharma Stock to Invest In Right Now?

Insider Monkey

a month ago

Is Teva Pharmaceutical Industries Limited (TEVA) the Best Low Price Pharma Stock to Invest In Right Now?

2025 Community Routes: Access to Mental Health Care Grants Awarded to Clinics in Alabama, Mississippi, and Texas, Funded by Teva Pharmaceuticals

GlobeNewswire

a month ago

2025 Community Routes: Access to Mental Health Care Grants Awarded to Clinics in Alabama, Mississippi, and Texas, Funded by Teva Pharmaceuticals

Teva and Medincell Announce FDA Acceptance of Supplemental New Drug Application for UZEDY® (risperidone) Extended-Release Injectable Suspension as a Treatment for Patients with Bipolar I Disorder

Business Wire

a month ago

Teva and Medincell Announce FDA Acceptance of Supplemental New Drug Application for UZEDY® (risperidone) Extended-Release Injectable Suspension as a Treatment for Patients with Bipolar I Disorder

Teva Pharmaceutical Industries Limited (TEVA): Among Bourgeon Capital’s Top Stock Picks

Insider Monkey

a month ago

Teva Pharmaceutical Industries Limited (TEVA): Among Bourgeon Capital’s Top Stock Picks

Sanofi/Teva Unveil New Detailed Data For Duvakitug Study Supporting Overall Efficacy For Common Inflammatory Bowel Disease

Benzinga

a month ago

Sanofi/Teva Unveil New Detailed Data For Duvakitug Study Supporting Overall Efficacy For Common Inflammatory Bowel Disease

Teva and Alvotech launch ustekinumab biosimilar injection in US

Pharmaceutical Technology

a month ago

Teva and Alvotech launch ustekinumab biosimilar injection in US

Sanofi, Teva add to case for new bowel disease drug

BioPharma Dive

a month ago

Sanofi, Teva add to case for new bowel disease drug

Sanofi and Teva report new outcomes from Phase IIb trial of duvakitug

Clinical Trials Arena

a month ago

Sanofi and Teva report new outcomes from Phase IIb trial of duvakitug

Teva and Sanofi Present New Positive Phase 2b Study Results at ECCO 2025 Reinforcing Best-in-Class Potential of Duvakitug (Anti-TL1A) in Ulcerative Colitis and Crohn’s Disease

GlobeNewswire

a month ago

Teva and Sanofi Present New Positive Phase 2b Study Results at ECCO 2025 Reinforcing Best-in-Class Potential of Duvakitug (Anti-TL1A) in Ulcerative Colitis and Crohn’s Disease

MT Newswires

a month ago

Teva Pharmaceutical US Affiliate, Alvotech Selarsdi Injection Now Available in US

Teva and Alvotech Announce SELARSDI™ (ustekinumab-aekn) Injection Now Available in the U.S.

GlobeNewswire

a month ago

Teva and Alvotech Announce SELARSDI™ (ustekinumab-aekn) Injection Now Available in the U.S.

Billionaire Stanley Druckenmiller Dumped Duquesne's Entire Stake in Broadcom and Bought One of Wall Street's Hottest Drug Stocks Hand Over Fist

Motley Fool

a month ago

Billionaire Stanley Druckenmiller Dumped Duquesne's Entire Stake in Broadcom and Bought One of Wall Street's Hottest Drug Stocks Hand Over Fist

MT Newswires

a month ago

Teva Pharmaceutical Industries Insider Sold Shares Worth $1,279,661, According to a Recent SEC Filing

Is Teva Pharmaceutical (TEVA) Trading at a Discount?

Insider Monkey

a month ago

Is Teva Pharmaceutical (TEVA) Trading at a Discount?

Teva to Host Conference Call on February 24, 2025 to Discuss New Data Presented for Duvakitug (anti-TL1A) Positive Phase 2b results at the 20th Annual Congress of the European Crohn's and Colitis Organisation (ECCO)

GlobeNewswire

a month ago

Teva to Host Conference Call on February 24, 2025 to Discuss New Data Presented for Duvakitug (anti-TL1A) Positive Phase 2b results at the 20th Annual Congress of the European Crohn's and Colitis Organisation (ECCO)

FDA To Review Teva and Alvotech Drug That Could Compete With Regeneron's Eylea

Investopedia

a month ago

FDA To Review Teva and Alvotech Drug That Could Compete With Regeneron's Eylea

MT Newswires

a month ago

Alvotech, Teva Pharmaceutical's Bionsimlar Eye Disorder Potential Treatment Accepted for FDA Review

Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Application for AVT06, a Proposed Biosimilar to Eylea® (aflibercept)

GlobeNewswire

a month ago

Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Application for AVT06, a Proposed Biosimilar to Eylea® (aflibercept)

GuruFocus.com

2 months ago

Stanley Druckenmiller's Strategic Moves: A Closer Look at Teva Pharmaceutical Industries Ltd

MT Newswires

2 months ago

Teva Pharmaceutical Industries Insider Sold Shares Worth $2,886,565, According to a Recent SEC Filing

Axsome Stock Surges 20% on Auvelity Patent Settlement With Teva

Zacks

2 months ago

Axsome Stock Surges 20% on Auvelity Patent Settlement With Teva

Axsome Therapeutics Resolves Generic Patent Litigation With Teva Over Depression Drug, Analyst Maintains Axsome As 'Top Pick For 2025'

Benzinga

2 months ago

Axsome Therapeutics Resolves Generic Patent Litigation With Teva Over Depression Drug, Analyst Maintains Axsome As 'Top Pick For 2025'

MT Newswires

2 months ago

Update: Axsome Therapeutics Shares Rise Following Deal to Settle Auvelity Patent Litigation With Teva

MT Newswires

2 months ago

Axsome, Teva Settle Auvelity Patent Litigation

Argus Research

2 months ago

Weekly Stock List

Axsome secures top drug’s future with Teva patent settlement

BioPharma Dive

2 months ago

Axsome secures top drug’s future with Teva patent settlement

MT Newswires

2 months ago

Teva Pharmaceutical Industries Files Mixed Shelf Registration

Teva Pharmaceutical Industries Full Year 2024 Earnings: EPS Misses Expectations

Simply Wall St.

2 months ago

Teva Pharmaceutical Industries Full Year 2024 Earnings: EPS Misses Expectations

MT Newswires

2 months ago

Saverone 2014 Wins Contract To Equip Teva Pharmaceutical's 50-Truck Fleet With Safety System

This Drug Stock Sits On A Strong Earnings Foundation As It Tests New Entry

Investor's Business Daily

2 months ago

This Drug Stock Sits On A Strong Earnings Foundation As It Tests New Entry

Argus Research

2 months ago

Analyst Report: Teva Phar Inds Lt

Argus Research

2 months ago

Market Digest: TEVA, AAPL, CMA, FCX, FLEX, LAZ, TMUS, MA

Teva Pharmaceutical Industries Ltd (TEVA) Q4 2024 Earnings Call Highlights: Strong Revenue ...

GuruFocus.com

2 months ago

Teva Pharmaceutical Industries Ltd (TEVA) Q4 2024 Earnings Call Highlights: Strong Revenue ...

TEVA Stock Down 14% Despite Q4 Earnings & Revenues Beat Estimates

Zacks

2 months ago

TEVA Stock Down 14% Despite Q4 Earnings & Revenues Beat Estimates

Why Teva Pharmaceuticals (TEVA) Crashed on Wednesday?

Insider Monkey

2 months ago

Why Teva Pharmaceuticals (TEVA) Crashed on Wednesday?

Morningstar Research

2 months ago

Analyst Report: Teva Pharmaceutical Industries Limited

Why Teva Pharmaceutical Stock Is Sinking Today

Motley Fool

2 months ago

Why Teva Pharmaceutical Stock Is Sinking Today

Teva Pharmaceutical Industries (TEVA) Q4 2024 Earnings Call Transcript

Motley Fool

2 months ago

Teva Pharmaceutical Industries (TEVA) Q4 2024 Earnings Call Transcript

MT Newswires

2 months ago

Sector Update: Health Care Stocks Softer in Afternoon Trading

Teva Stock Dives 14%. 'We're Victims Of Our Own Success,' Says CEO.

Investor's Business Daily

2 months ago

Teva Stock Dives 14%. 'We're Victims Of Our Own Success,' Says CEO.

Trump Media's Truth.Fi, T-Mobile, Teva: Market Minute

Yahoo Finance Video

2 months ago

Trump Media's Truth.Fi, T-Mobile, Teva: Market Minute

MT Newswires

2 months ago

Update: Teva Pharmaceutical Shares Drop After Q4 Non-GAAP Earnings, Revenue Fall

Teva Pharmaceutical Posts Lower Revenue. Stock Slips.

Investor's Business Daily

2 months ago

Teva Pharmaceutical Posts Lower Revenue. Stock Slips.

MT Newswires

2 months ago

Sector Update: Health Care Stocks Mixed Pre-Bell Wednesday

MT Newswires

2 months ago

Sector Update: Health Care

MT Newswires

2 months ago

Teva Pharmaceutical Q4 Non-GAAP Earnings, Revenue Fall; 2025 Outlook Issued

Teva Delivers Second Consecutive Year of Growth; Announces Strong Financial Results in Fourth Quarter and Full Year 2024, Led by Generics Performance and Innovative Portfolio Growth

GlobeNewswire

2 months ago

Teva Delivers Second Consecutive Year of Growth; Announces Strong Financial Results in Fourth Quarter and Full Year 2024, Led by Generics Performance and Innovative Portfolio Growth

MT Newswires

2 months ago

Alvotech, Teva Filing for Inflammatory Treatment Candidate Accepted for FDA Review

Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Applications for AVT05, a Proposed Biosimilar to Simponi® and Simponi Aria® (golimumab)

GlobeNewswire

2 months ago

Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Applications for AVT05, a Proposed Biosimilar to Simponi® and Simponi Aria® (golimumab)

FDA adds boxed warning to multiple sclerosis drugs after anaphylaxis cases

Pharmaceutical Technology

2 months ago

FDA adds boxed warning to multiple sclerosis drugs after anaphylaxis cases

Ozempic, Xtandi among next 15 drugs selected for U.S. price talks

TipRanks

2 months ago

Ozempic, Xtandi among next 15 drugs selected for U.S. price talks

MT Newswires

3 months ago

Update: Novo Nordisk's Ozempic, Wegovy Among Drugs Chosen for US Medicare Price Talks

Novo Nordisk's stock down 4% as the Feds get ready for a second round of drug price negotiations

Yahoo Finance

3 months ago

Novo Nordisk's stock down 4% as the Feds get ready for a second round of drug price negotiations

How Teva Pharmaceuticals is thinking about Trump's return: CEO

Yahoo Finance Video

3 months ago

How Teva Pharmaceuticals is thinking about Trump's return: CEO

Amicus Posts Preliminary 2024 Results, Issues 2025 Outlook

Zacks

3 months ago

Amicus Posts Preliminary 2024 Results, Issues 2025 Outlook

MT Newswires

3 months ago

Teva Pharmaceuticals International Enters Collaboration to Commercialize Eye Disease Treatment

Teva Announces Collaboration to Commercialize Formycon’s Biosimilar Candidate to Eylea® (aflibercept) in major parts of Europe and in Israel

GlobeNewswire

3 months ago

Teva Announces Collaboration to Commercialize Formycon’s Biosimilar Candidate to Eylea® (aflibercept) in major parts of Europe and in Israel

MT Newswires

3 months ago

Teva Pharmaceutical, Samsung Bioepis to Commercialize Epysqli in US

Samsung Bioepis and Teva Enter into a Strategic Partnership for Commercialization of EPYSQLI® (eculizumab-aagh) in the United States

GlobeNewswire

3 months ago

Samsung Bioepis and Teva Enter into a Strategic Partnership for Commercialization of EPYSQLI® (eculizumab-aagh) in the United States

Biotech Stock Roundup: NMRA Plunges on Study Failure, HOTH, VIR Soar on Study Data & More

Zacks

3 months ago

Biotech Stock Roundup: NMRA Plunges on Study Failure, HOTH, VIR Soar on Study Data & More

Catalyst Pharmaceuticals Settles Patent Litigation Case With Teva Pharmaceutical

Benzinga

3 months ago

Catalyst Pharmaceuticals Settles Patent Litigation Case With Teva Pharmaceutical

CPRX Stock Rises 17% on Settling Firdapse Patent Litigation With Teva

Zacks

3 months ago

CPRX Stock Rises 17% on Settling Firdapse Patent Litigation With Teva

IBD Tech Leader Catalyst Rockets After Striking A Key Deal With Teva

Investor's Business Daily

3 months ago

IBD Tech Leader Catalyst Rockets After Striking A Key Deal With Teva

MT Newswires

3 months ago

Sector Update: Health Care Stocks Advance Late Afternoon

MT Newswires

3 months ago

Sector Update: Health Care Stocks Higher in Afternoon Trading

Why Teva Pharmaceuticals Industries Ltd. (TEVA) Crashed Yesterday

Insider Monkey

3 months ago

Why Teva Pharmaceuticals Industries Ltd. (TEVA) Crashed Yesterday

Argus Research

3 months ago

Weekly Stock List

Teva Pharmaceutical Industries Ltd (TEVA) Ends Trading Week Defying Market Bloodbath

Insider Monkey

3 months ago

Teva Pharmaceutical Industries Ltd (TEVA) Ends Trading Week Defying Market Bloodbath

MT Newswires

3 months ago

Teva Pharmaceutical Industries Insider Sold Shares Worth $6,294,031, According to a Recent SEC Filing

Billionaire Stanley Druckenmiller Is Selling Nvidia and Palantir and Piling Into One of Wall Street's Hottest Drug Stocks Ahead of 2025

Motley Fool

3 months ago

Billionaire Stanley Druckenmiller Is Selling Nvidia and Palantir and Piling Into One of Wall Street's Hottest Drug Stocks Ahead of 2025

Why Teva Pharmaceuticals Industries (TEVA) Skyrocketed?

Insider Monkey

3 months ago

Why Teva Pharmaceuticals Industries (TEVA) Skyrocketed?

Teva to Present at the 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewswire

3 months ago

Teva to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Teva Pharmaceutical Industries Limited (TEVA): A Bull Case Theory

Insider Monkey

3 months ago

Teva Pharmaceutical Industries Limited (TEVA): A Bull Case Theory

Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial Results and 2025 Financial Guidance at 8 a.m. ET on January 29, 2025

GlobeNewswire

3 months ago

Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial Results and 2025 Financial Guidance at 8 a.m. ET on January 29, 2025

Pharma Stock Roundup: PFE's 2025 Outlook, MRK & ABBV's M&A Deals

Zacks

3 months ago

Pharma Stock Roundup: PFE's 2025 Outlook, MRK & ABBV's M&A Deals

My Top 10 Portfolio Holdings for 2025

Motley Fool

3 months ago

My Top 10 Portfolio Holdings for 2025

Teva price target raised to $28 from $26 at UBS

TipRanks

3 months ago

Teva price target raised to $28 from $26 at UBS

Jim Cramer on Teva Pharmaceutical Industries (TEVA): A Game-Changer for Intractable Disease Treatments?

Insider Monkey

3 months ago

Jim Cramer on Teva Pharmaceutical Industries (TEVA): A Game-Changer for Intractable Disease Treatments?

MT Newswires

3 months ago

Teva Pharmaceutical Stock Positioned for Even Better Performance in 2025, UBS Says

MT Newswires

3 months ago

BofA Securities Raises Price Target on Teva Pharmaceutical Industries to $25 From $23, Keeps Buy Rating

SNY, TEVA Stocks Jump on Encouraging Data From IBD Drug Study

Zacks

3 months ago

SNY, TEVA Stocks Jump on Encouraging Data From IBD Drug Study

Share on Social Networks: